Time to revise WHO-recommended definitions of MDR-TB treatment outcomes

C. Lange; F. van Leth; C.D. Mitnick; K. Dheda; G. Günther

doi:10.1016/S2213-2600(18)30104-8

Time to revise WHO-recommended definitions of MDR-TB treatment outcomes

C. Lange, F. van Leth, C.D. Mitnick, K. Dheda, G. Günther

Research output: Contribution to Journal › Comment / Letter to the editor › Academic

Original language	English
Pages (from-to)	246-248
Journal	The Lancet Respiratory Medicine
Volume	6
Issue number	4
DOIs	https://doi.org/10.1016/S2213-2600(18)30104-8
Publication status	Published - 1 Apr 2018
Externally published	Yes

Funding

CL reports personal fees from Chiesi, Gilead, Abbvie, Merck Sharp & Dohme, Becton Dickinson, Janssen, Lucane, Novartis, and Thermo Fisher Scientific, outside of the submitted work. KD reports grants and personal fees from ALERE, Oxford Immunotec, Cellestis (now Qiagen), Cepheid, Antrum Biotec, and Hain Lifescience, and grants from FIND, eNose Company, Statens Serum Institut, bioMeriux, outside of the submitted work. KD also has patents (characterisation of novel tuberculosis-specific urinary biomarkers and smart mask for monitoring cough-related infectious diseases) pending, and a patent (device for diagnosing extrapulmonary tuberculosis) issued. All other authors declare no competing interests.

Funders	Funder number
Antrum Biotec
FIND
Hain Lifescience

Access to Document

10.1016/S2213-2600(18)30104-8

Persistent URL (handle)

Persistent link

TBnet: Multidrug resistant tuberculosis in Europe
van Leth, F.
1/06/09 → 31/12/14
Project: Research

Cite this

@article{93a79dd0cd844894b64b2271e2f7afd5,

title = "Time to revise WHO-recommended definitions of MDR-TB treatment outcomes",

author = "C. Lange and {van Leth}, F. and C.D. Mitnick and K. Dheda and G. G{\"u}nther",

year = "2018",

month = apr,

day = "1",

doi = "10.1016/S2213-2600(18)30104-8",

language = "English",

volume = "6",

pages = "246--248",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Limited",

number = "4",

}

TY - JOUR

T1 - Time to revise WHO-recommended definitions of MDR-TB treatment outcomes

AU - Lange, C.

AU - van Leth, F.

AU - Mitnick, C.D.

AU - Dheda, K.

AU - Günther, G.

PY - 2018/4/1

Y1 - 2018/4/1

U2 - 10.1016/S2213-2600(18)30104-8

DO - 10.1016/S2213-2600(18)30104-8

M3 - Comment / Letter to the editor

SN - 2213-2600

VL - 6

SP - 246

EP - 248

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 4

ER -

Time to revise WHO-recommended definitions of MDR-TB treatment outcomes

Funding

Access to Document

Persistent URL (handle)

Projects

TBnet: Multidrug resistant tuberculosis in Europe

Cite this